 Perrigo Company plcs NYSE: PRGO Q1 FY22 sales increased 6.4 YY to 1.07 billion, almost in line with the consensus of 1.1 billion. The growth was led by strong consumer demand, particularly for coughcold products globally and infant formula in the U.S. after. 